The translational challenges in the field of precision oncology are in part related to the
biological complexity and diversity of this disease. Technological advances in genomics …

The last 50 years of hepatitis B research has resulted in the development of effective
screening assays for surveillance, vaccines for prevention and antiviral drugs that …

Adjuvanted soluble protein vaccines have been used extensively in humans for protection
against various viral infections based on their robust induction of antibody responses. Here …

These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …

In infants born to hepatitis B surface antigen (HBsAg)–positive mothers, failure after passive–
active immunization still occurs. The role of maternal hepatitis B DNA level and other risk …

BACKGROUND & AIMS: Immunoprophylaxis reduces but does not completely eradicate
hepatitis B virus (HBV) transmission. This prospective study aims at assessing the rate and …

BACKGROUND & AIMS: Mother-to-infant transmission is the major cause of hepatitis B virus
(HBV) infection among immunized children. There has been much debate about screening …

The development of aluminum salts (alum) as vaccine adjuvants was an empirical process
with little understanding of the mechanism of action and, with decades of use, it has become …

Since 1982, safe and effective hepatitis B virus (HBV) vaccines have been commercially
available first derived from plasma of HBV infected persons and later from yeast cells using …

In this review the current overall knowledge on hepatitis A, B, C, D, and E will be discussed.
These diseases are all characterized by liver inflammation but have significant differences in …